Cargando…

Assessment of Plasma Amyloid-β(42/40) and Cognitive Decline Among Community-Dwelling Older Adults

IMPORTANCE: Plasma measurement of amyloid-β (Aβ) peptides has been associated with cognitive function, but evidence of its ability to identify cognitive decline is still scarce. OBJECTIVE: To investigate the associations between plasma Aβ(42/40) and cognitive decline over time among community-dwelli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giudici, Kelly Virecoulon, de Souto Barreto, Philipe, Guyonnet, Sophie, Li, Yan, Bateman, Randall John, Vellas, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747018/ https://www.ncbi.nlm.nih.gov/pubmed/33331917 http://dx.doi.org/10.1001/jamanetworkopen.2020.28634

Ejemplares similares

Body Weight Variation Patterns as Predictors of Cognitive Decline over a 5 Year Follow-Up among Community-Dwelling Elderly (MAPT Study)
por: Giudici, Kelly Virecoulon, et al.
Publicado: (2019)

Associations Between Nutritional Deficits and Physical Performance in Community-Dwelling Older Adults
por: Lu, Wan-Hsuan, et al.
Publicado: (2021)

Interactions Between Plasma Amyloid and Aging Markers to Determine Clinically Meaningful Cognitive Decline
por: Lu, Wan-Hsuan, et al.
Publicado: (2021)

Plasma MCP-1 and changes on cognitive function in community-dwelling older adults
por: Sanchez-Sanchez, Juan Luis, et al.
Publicado: (2022)

Association between urate-lowering therapies and cognitive decline in community-dwelling older adults
por: Molet-Benhamou, Luc, et al.
Publicado: (2022)

A 1‐year randomized controlled trial of a nutritional blend to improve nutritional biomarkers and prevent cognitive decline among community‐dwelling older adults: The Nolan Study
por: Giudici, Kelly V., et al.
Publicado: (2022)

Plasma inflammation‐related biomarkers are associated with intrinsic capacity in community‐dwelling older adults
por: Lu, Wan‐Hsuan, et al.
Publicado: (2023)

Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
por: Janelidze, Shorena, et al.
Publicado: (2021)

Cross-sectional associations of plasma vitamin D with cerebral β-amyloid in older adults at risk of dementia
por: Nourhashemi, Fati, et al.
Publicado: (2018)

Plasma Aβ and neurofilament light chain are associated with cognitive and physical function decline in non-dementia older adults
por: He, Lingxiao, et al.
Publicado: (2020)

Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial
por: Delrieu, Julien, et al.
Publicado: (2023)

Predictors of decline in walking ability in community-dwelling Alzheimer’s disease patients: Results from the 4-years prospective REAL.FR study
por: Rolland, Yves, et al.
Publicado: (2013)

Plasma neurofilament light chain is associated with cognitive decline in non-dementia older adults
por: He, Lingxiao, et al.
Publicado: (2021)

Periostin Plasma Levels and Changes on Physical and Cognitive Capacities in Community-Dwelling Older Adults
por: Sánchez-Sánchez, Juan Luis, et al.
Publicado: (2022)

Effect of Long-Term Omega 3 Polyunsaturated Fatty Acid Supplementation with or without Multidomain Lifestyle Intervention on Muscle Strength in Older Adults: Secondary Analysis of the Multidomain Alzheimer Preventive Trial (MAPT)
por: Rolland, Yves, et al.
Publicado: (2019)

Plasma amyloid-β42/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer’s disease
por: Cullen, Nicholas C, et al.
Publicado: (2023)

Cross-sectional Associations of Fatigue with Cerebral β-Amyloid in Older Adults at Risk of Dementia
por: Hooper, Claudie, et al.
Publicado: (2017)

Systematic Dementia Screening by Multidisciplinary Team Meetings in Nursing Homes for Reducing Emergency Department Transfers: The IDEM Cluster Randomized Clinical Trial
por: Rolland, Yves, et al.
Publicado: (2020)

Defining Vitality Using Physical and Mental Well-Being Measures in Nursing Homes: A Prospective Study
por: Masciocchi, E., et al.
Publicado: (2019)

Physical activity and exercise in the context of SARS-Cov-2: A perspective from geroscience field
por: de Souto Barreto, Philipe, et al.
Publicado: (2021)

Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40
por: Wisch, Julie K., et al.
Publicado: (2023)

A Web-Based Multidomain Lifestyle Intervention for Older Adults: The eMIND Randomized Controlled Trial
por: de Souto Barreto, Philipe, et al.
Publicado: (2020)

Nutrition-Based Approaches in Clinical Trials Targeting Cognitive Function: Highlights of the CTAD 2020
por: Giudici, Kelly Virecoulon
Publicado: (2021)

A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics
por: Al- Ayadhi, Laila Y, et al.
Publicado: (2012)

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
por: Fandos, Noelia, et al.
Publicado: (2017)

Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40?
por: Klafki, Hans-Wolfgang, et al.
Publicado: (2022)

Impact of nursing home‐acquired pneumonia on the domains of the novel construct of intrinsic capacity: The INCUR study
por: Sánchez‐Sánchez, Juan Luis, et al.
Publicado: (2022)

Reduction prevalence of fragility fracture hospitalisation during the COVID-19 lockdown
por: de Souto Barreto, Philipe, et al.
Publicado: (2022)

Using Drosophila to identify naturally occurring genetic modifiers of amyloid beta 42- and tau-induced toxicity
por: Yang, Ming, et al.
Publicado: (2023)

Is postoperative cognitive decline after cardiac surgery associated with plasma beta amyloid 1–42 levels?
por: Požgain, Zrinka, et al.
Publicado: (2022)

A Self-Reported Screening Tool for Detecting Community-Dwelling Older Persons with Frailty Syndrome in the Absence of Mobility Disability: The FiND Questionnaire
por: Cesari, Matteo, et al.
Publicado: (2014)

Combination of plasma amyloid beta((1-42/1-40)) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
por: Verberk, Inge M. W., et al.
Publicado: (2020)

Vascular Risk Predicts Plasma Amyloid β 42/40 Through Cerebral Amyloid Burden in Apolipoprotein E ε4 Carriers
por: Sapkota, Shraddha, et al.
Publicado: (2023)

Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment
por: Hu, Yan, et al.
Publicado: (2022)

Stability of Plasma Amyloid-β 1–40, Amyloid-β 1–42, and Total Tau Protein over Repeated Freeze/Thaw Cycles
por: Liu, Huei-Chun, et al.
Publicado: (2020)

Cross-sectional associations between cortical thickness and physical activity in older adults with spontaneous memory complaints: The MAPT Study
por: Raffin, Jérémy, et al.
Publicado: (2023)

Amyloid related cerebral microbleed and plasma Aβ40 are associated with cognitive decline in Parkinson’s disease
por: Tsai, Hsin-Hsi, et al.
Publicado: (2021)

Amyloid-β peptide 37, 38 and 40 individually and cooperatively inhibit amyloid-β 42 aggregation
por: Braun, Gabriel A., et al.
Publicado: (2022)

The HSP40 chaperone Ydj1 drives amyloid beta 42 toxicity
por: Ring, Julia, et al.
Publicado: (2022)

Diagnostic Utility of Selected Serum Dementia Biomarkers: Amyloid β-40, Amyloid β-42, Tau Protein, and YKL-40: A Review
por: Wilczyńska, Karolina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aet8iplp0m7htm2thcr40ji28m